Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SII enrols 6000 subjects for efficacy trial of rBCG vaccine, VPM1002 against COVID-19

expresspharmaJuly 28, 2020

Tag: SII , BCG vaccine , VPM1002 , COVID-19

PharmaSources Customer Service